Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etifoxine as adjunctive treatment in medically resistant focal epilepsy with comorbid anxiety (The ETIFOXs)
TCTR20210925001Phase 2Recruiting
- Sponsor
- Faculty of Pharmaceutical Sciences, Burapha University
- Start
- Apr 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of etifoxine in Focal Onset Epilepsy and anxiety disorder, sponsored by Faculty of Pharmaceutical Sciences, Burapha University. Started Apr 2021; status: recruiting.
02
Drugs
etifoxine
03
Conditions
Focal Onset Epilepsyanxiety disorder
Beyond the preview
Go deeper on TCTR20210925001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210925001.